Tanaka N et al. suggested that combined chemotherapy with cytokines (IFN-a plus TNF-a) and 5-FU may be a therapeutic modality for advanced pancreatic cancer [14]. The gene discussed is TNF; the disease is familial pancreatic carcinoma.